Renaissance Technologies LLC Has $880,000 Stock Position in agilon health, inc. (NYSE:AGL)

Renaissance Technologies LLC lifted its stake in shares of agilon health, inc. (NYSE:AGL) by 155.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 463,300 shares of the company’s stock after purchasing an additional 281,700 shares during the quarter. Renaissance Technologies LLC owned about 0.11% of agilon health worth $880,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Oak Thistle LLC bought a new position in shares of agilon health during the fourth quarter valued at about $25,000. Ieq Capital LLC purchased a new position in shares of agilon health in the fourth quarter valued at $26,000. Signaturefd LLC lifted its holdings in shares of agilon health by 143.0% in the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company’s stock worth $27,000 after buying an additional 8,467 shares in the last quarter. Raymond James Financial Inc. bought a new position in agilon health in the 4th quarter valued at $33,000. Finally, Cerity Partners LLC bought a new stake in agilon health during the fourth quarter valued at $34,000.

agilon health Stock Down 8.3 %

AGL stock opened at $3.91 on Friday. agilon health, inc. has a fifty-two week low of $1.50 and a fifty-two week high of $7.73. The company has a market cap of $1.61 billion, a price-to-earnings ratio of -4.16 and a beta of 0.38. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The business’s 50-day moving average is $4.22 and its two-hundred day moving average is $3.16.

Wall Street Analysts Forecast Growth

AGL has been the topic of several research reports. Needham & Company LLC restated a “hold” rating on shares of agilon health in a research report on Friday, March 21st. Robert W. Baird decreased their price objective on shares of agilon health from $6.00 to $5.00 and set a “neutral” rating on the stock in a research report on Tuesday, April 15th. Royal Bank of Canada raised their price target on agilon health from $3.00 to $3.50 and gave the stock an “outperform” rating in a research note on Wednesday, February 26th. Stifel Nicolaus increased their target price on agilon health from $2.00 to $3.00 and gave the stock a “hold” rating in a research report on Wednesday, February 26th. Finally, Sanford C. Bernstein upgraded shares of agilon health from a “market perform” rating to an “outperform” rating and upped their price objective for the stock from $3.30 to $8.50 in a report on Tuesday, April 8th. Two investment analysts have rated the stock with a sell rating, twelve have issued a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, agilon health has an average rating of “Hold” and an average price target of $4.81.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.